×
About 725 results

ALLMedicine™ Metastatic Bone Disease Center

Research & Reviews  248 results

Machine learning algorithms to estimate 10-Year survival in patients with bone metastas...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055684
BMC Cancer; Anderson AB, Grazal C et. al.

May 1st, 2022 - Prognostic indicators, treatments, and survival estimates vary by cancer type. Therefore, disease-specific models are needed to estimate patient survival. Our primary aim was to develop models to estimate survival duration after treatment for skel...

Electrochemotherapy Is Effective in the Treatment of Bone Metastases.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947745
Current Oncology (Toronto, Ont.); Campanacci L, Cevolani L et. al.

Mar 25th, 2022 - Bone metastases induce pain, risk of fracture, and neural compression, and reduced mobility and quality of life. Electrochemotherapy (ECT) is a minimally invasive local treatment based on a high-voltage electric pulse combined with an anticancer d...

Association of the Oncology Care Model With Value-Based Changes in Use of Radiation The...
https://doi.org/10.1016/j.ijrobp.2022.01.044
International Journal of Radiation Oncology, Biology, Phy... Kapadia NS, Brooks GA et. al.

Feb 13th, 2022 - Radiation utilization for breast cancer and metastatic bone disease varies in modality, fractionation, and cost, despite evidence demonstrating equal effectiveness and consensus recommendations such as Choosing Wisely that advocate for higher valu...

Percutaneous Screw Stabilization of Non-Periacetabular Pelvic Lesions Caused by Metasta...
https://doi.org/10.2106/JBJS.21.00518
The Journal of Bone and Joint Surgery. American Volume; Yang R, Singh S et. al.

Feb 10th, 2022 - The pelvis is one of the most common locations for metastatic bone disease. While many of the publications that describe surgical treatments focus on periacetabular lesions (Enneking zone II), there is a lack of investigation into lesions in the n...

Bilateral Testicular Mass Presenting as a Rare Manifestation of Extramedullary Plasmacy...
https://doi.org/10.1097/RLU.0000000000004043
Clinical Nuclear Medicine; Civan C, Apaydin Arikan E et. al.

Jan 14th, 2022 - We present the case of a 48-year-old man diagnosed with metastatic Ewing sarcoma who was referred for 18F-FDG PET/CT for treatment response evaluation following chemoradiotherapy. The patient also had complaints of new-onset testicular swelling at...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  8 results

Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans
https://clinicaltrials.gov/ct2/show/NCT05110430

Nov 8th, 2021 - Bone scintigraphy scans are two dimensional medical images that are used heavily in nuclear medicine. The scans detect changes in bone metabolism with high sensitivity, yet it lacks the specificity to underlying causes. Therefore, further imaging ...

Surgical Treatment of Long Bone Metastases
https://clinicaltrials.gov/ct2/show/NCT03188926

Aug 4th, 2020 - The objectives of this study were to examine clinical outcomes after reconstruction with intramedullary fixation (IMN) or endoprosthetic reconstruction (EPR) with a specific focus on (1) the rate of complication or failure; (2) differences in comp...

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
https://clinicaltrials.gov/ct2/show/NCT00478270

Aug 16th, 2017 - This single arm study will assess the efficacy of loading doses of intravenous Bondronat in reducing pain in patients with breast cancer and metastatic bone disease experiencing moderate to severe bone pain. Patients will receive an intravenous in...

A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
https://clinicaltrials.gov/ct2/show/NCT02373904

Aug 1st, 2017 - The purpose of this study is to collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of painful impending and actual fractures of the humerus secondary to metastatic cancer.

Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.
https://clinicaltrials.gov/ct2/show/NCT02174107

Jan 10th, 2017 - Bone is the most common site for metastasis. In breast and prostate cancers, 70% of patients dying of their cancer have evidence of metastatic bone disease [Coleman, 2006]. Depending on their localization, bone metastases can have debilitating con...

see more →

News  33 results

Collaborations With Orthopedic Surgeons, Interventional Radiologists Key to Novel Approaches in Metastatic Bone Cancer
https://www.onclive.com/view/collaborations-with-orthopedic-surgeons-interventional-radiologists-key-to-novel-approaches-in-metastatic-bone-cancer

Feb 15th, 2022 - Medical oncologists who have patients with metastatic bone cancer should consult with orthopedic surgeons and interventional radiologists to provide patients with improved or minimally invasive therapeutic options, according to R. Lor Randall, MD....

Orthopedic Oncologists Essential to Optimal QoL for Patients With Metastatic Bone Disease
https://www.onclive.com/view/orthopedic-oncologists-essential-to-optimal-qol-for-patients-with-metastatic-bone-disease

Oct 6th, 2021 - R. Lor Randall, MD, FACS Orthopedic oncologists are the stewards of the musculoskeletal system, according to R. Lor Randall, MD, FACS. Therefore, he said, more medical oncologists should refer their patients with metastatic bone disease to orthop...

Cancer-Associated Pain Clinical Practice Guidelines (ASPN, 2021)
https://www.medscape.com/viewarticle/958123

Sep 3rd, 2021 - Guidelines on the interventional management of cancer-associated pain were published in July 2021 by the American Society of Pain and Neuroscience in the Journal of Pain Research.[1] Opioids Consider using opioids for patients with moderate-to-sev...

Tracking the Oncology Pipeline: Developments From ESMO
https://www.onclive.com/view/tracking-the-oncology-pipeline-developments-from-esmo

Dec 20th, 2020 - The latest research on several investigational cancer therapies was presented at the European Society for Medical Oncology (ESMO) 2012 Congress, which took place from September 28-October 2 in Vienna, Austria. Below is a highlight of several key p...

Expert Discusses State of Bone-Targeted Therapy in Breast Cancer
https://www.onclive.com/view/expert-discusses-state-of-bonetargeted-therapy-in-breast-cancer

Dec 20th, 2020 - Adam M. Brufsky, MD, PhD Certain bone-targeted agents deserve more frequent use in oncology, although providers need to be mindful about patient conditions and the potential for osteonecrosis, said Adam M. Brufsky, MD, PhD, who provided an update...

see more →